Markets of interest Exemestane is an aromatase inhibitor which belongs to a class of antiestrogens and used to treat breast cancer. The medication as an estrogen inhibitor blocks aromatase enzyme, which is responsible for estrogen synthesis. As a result, by lowering estrogen level, the drug slows the growth of cancer. The drug is available for sale in different forms such as film coated tablets (at concentration 25mg, 50mg, 100mg, 150mg, 200mg, 300mg) and tablets (at concentration of 25mg) from manufacturers in various countries including Y. The leading exemestane manufacturers and distributors are based in India and China. Licensing and brand names Exemestane was approved by the FDA in 1999 for treatment of advanced breast cancer in postmenopausal women whose tumors have stopped responding to tamoxifen. The drug is available for sale as a generic medication. Exemestane is marketed in most of the countries under the trade names Aromasin. The leading exemestane supplier and manufacturer is the Indian company Actiza Pharmaceutical. Other manufacturing companies from European Union, Australia and Turkey have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with exemestane as an active ingredient. Target supply price The wholesale acquisition cost of the exemestane medication in the United States ranges from 115 USD for 30 tablets pack (at concentration 25mg) to 220 USD for the pack of 90 tablets at the same concentration. The retail price in the EU depending on the amount of tablets in a pack varies between 125 and 405 EUR per pack. The medication wholesale prices and commercial terms can vary depending on the supplier. Information from manufacturers We provide a detailed list of the exemestane manufacturers and suppliers that you are looking for. You can also find the dossier status of the drug that you order, and the GMP approvals of the different variants of the medication. The product description of all exemestane suppliers contains essential information about the medication, including clinical data, stability zones, and a list of countries where exemestane is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms.Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified exemestane suppliers and distributors enter our online marketplace,offering you a risk-free global B2B pharmaceutical sales platform.